Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer



Results from a recent clinical trial showed that extending adjuvant therapy with an aromatase inhibitor to 10 years after initial treatment can have important benefits for postmenopausal women with early-stage hormone receptor–positive breast cancer.



Source link

Comments are closed.